We are live on ! Find out more
EAM

EFG Asset Management Portfolio holdings

AUM $773M
1-Year Est. Return 40.1%
This Fund
S&P 500
This Quarter Est. Return
-3.52%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
10 Year Est. Return
AUM
$421M
AUM Growth
-$44.9M
Cap. Flow
-$19.8M
Cap. Flow %
-4.71%
Top 10 Hldgs %
16.37%
Holding
207
New
16
Increased
62
Reduced
115
Closed
14

Top Buys

Rank Stock Value
1
ZS icon
Zscaler
ZS
+$2.72M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.86M
3
ROIV icon
Roivant Sciences
ROIV
+$1.84M
4
CERT icon
Certara
CERT
+$1.81M
5
GEHC icon
GE HealthCare
GEHC
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 37.85%
2 Technology 22.51%
3 Industrials 10.95%
4 Consumer Discretionary 10.86%
5 Communication Services 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXL icon
201
MaxLinear
MXL
$6.06B
-33,624
Closed -$1.06M
SAGE
202
DELISTED
Sage Therapeutics
SAGE
-21,003
Closed -$987K
USB icon
203
US Bancorp
USB
$98.2B
-13,583
Closed -$449K
WOLF icon
204
Wolfspeed
WOLF
$1.23B
-43,956
Closed -$2.44M
XNCR icon
205
Xencor
XNCR
$1.5B
-43,555
Closed -$1.09M
EXE
206
Expand Energy Corp
EXE
$21.8B
-5,349
Closed -$448K
SILK
207
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-20,994
Closed -$682K

Similar funds

EFG Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, EFG Asset Management held 207 positions worth $421M, down 9.6% from $466M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

EFG Asset Management withdrew a net $19.8M in Q3 2023, closing 14 positions and reducing 115 holdings. Its most notable exit was CoStar Group, an estimated $4.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Technology and Industrials.

Against the trend, EFG Asset Management opened a new position in Zscaler worth $2.82M.

  • EFG Asset Management's largest Q3 2023 buy was Zscaler: 18,131 shares worth $2.82M.
  • EFG Asset Management added most to BioMarin Pharmaceuticals in Q3 2023, an estimated $1.86M increase.
  • EFG Asset Management's biggest Q3 2023 reduction was Blueprint Medicines, cutting an estimated $3.38M.
  • EFG Asset Management fully exited CoStar Group in Q3 2023, selling an estimated $4.92M.
  • EFG Asset Management's ten largest holdings make up 16% of its $421M portfolio in Q3 2023.
  • EFG Asset Management opened 16 new positions and closed 14 in Q3 2023.
  • EFG Asset Management's portfolio value fell 9.6% quarter-over-quarter to $421M.

Based on EFG Asset Management's 13F filing for Q3 2023, filed 2 Nov 2023.